Clinical Trial Update: Pilot Study of the Effect of Trastuzumab and GM-CSF on Children With Recurrent Ependymoma [Phase 1]

View source ↗

Summary

A Phase 1 pilot trial is evaluating trastuzumab plus GM-CSF in children with recurrent posterior fossa ependymoma; the study is currently active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Posterior Fossa Ependymoma

Drugs mentioned

• HERCEPTIN (trastuzumab)
• Leukine (sargramostim)

Snippet

Sponsor: University of Colorado, Denver | Conditions: Posterior Fossa Ependymoma (PFEPN) | Phase 1 | Status: ACTIVE_NOT_RECRUITING